Global Sciatica Treatment Market 2019-2023 | 8% CAGR Projection Over the Next Five Years | Technavio
LONDON--(BUSINESS WIRE)--Apr 8, 2019--The global sciatica treatment market is expected to post a CAGR of close to 8% during the period 2019-2023, according to the latest market research report by Technavio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190408005042/en/
The global sciatica treatment market is expected to post a CAGR of close to 8% during the period 2019-2023 (Graphic: Business Wire)
A key factor driving the growth of the global sciatica treatment market is the growing prevalence of risk factors for sciatica. Sciatica often occurs due to disease conditions such as osteoarthritis, spondylolisthesis, muscle spasms, and lumbar spinal stenosis. The prevalence of these medical conditions is increasing significantly across the world. An increase in the incidence of these medical conditions may increase the chances of development of sciatica. This, in turn, will boost the use of available and anticipated treatments during the forecast period.
As per Technavio, the increasing funds for research on sciatica will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global sciatica treatment market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
Global sciatica treatment market: Development of clonidine micropellet epidural injections
Pharmaceutical companies are increasingly focusing on developing micropellet technology-based non-steroidal epidural injections for the treatment of patients with sciatica. This is mainly because no epidural steroids are approved for the treatment of sciatica. The micropellet technology-based epidural injection helps in reducing the pain and inflammation by allowing localized delivery of medication to the affected nerves. Moreover, the safety and efficacy of clonidine are expected to be better with this novel technology. The medications developed with micropellet technology will enter the market during the forecast period and add significant value to its growth.
“Sciatica can cause long-term pain in the lower back if the condition is left untreated. Many government and non-governmental organizations are initiating certain programs to increase awareness among people about the condition and avoid delay in diagnosis. Such increasing awareness programs help patients to know about the disease and available safe treatment options, which will drive market growth during the forecast period,” says a senior research analyst at Technavio.
Global sciatica treatment market: Segmentation analysis
This market research report segments the global sciatica treatment market by type (surgical treatment and non-surgical treatment) and geographic regions (North America, Europe, Asia, and ROW).
The non-surgical segment held the largest sciatica treatment market share in 2018. The growth of this segment is mainly driven by the availability of off-label epidural corticosteroid injections for the treatment of sciatica.
The North America region led the market in 2018 with a market share of more than 36%, followed by Europe, Asia, and ROW respectively. The market growth in North America can be attributed to the rising awareness about the condition and strategic alliances among vendors in the region.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base includes enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190408005042/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: SURGERY HEALTH GENERAL HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 04/08/2019 10:12 AM/DISC: 04/08/2019 10:12 AM